Dr. Anthony Hung Chau, MD

Dr. Chau practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Chau's NPI, 1699055988, was assigned on August 18, 2011. Dr. Chau graduated from David Geffen School of Medicine at UCLA in 2011. Dr. Chau holds California license A122915.

Dr. Chau's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Chau's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Chau to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chau practices. Vendor and product names are available with a free account.

Surgery is Dr. Chau's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Chau is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Chau's licenses on file in 3 states: California, Arizona and Montana.

Dmand AI lists amputation, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), leg revascularization, peripheral vascular disease and varicose veins among the conditions Dr. Chau treats.

CMS data shows 152 Medicare services from Dr. Chau across 4 procedure codes in 2024, for 112 Medicare patients. Medicare paid $12,045 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 112 Medicare patients who saw Dr. Chau in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 4.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chau's median patient age at 65, with 39% women.

In 2024, Dr. Chau wrote 26 Medicare Part D claims for 11 patients. 69% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $204 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dr. Chau accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chau as offering telehealth.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Chau, published from 2018 to 2025. 2018 was the busiest year, with 2. Dr. Chau's most frequent co-authors are Roy Masami Fujitani, MD, Nii-Kabu Kabutey, MD and Isabella Jade Kuo, MD.

Dmand AI links Dr. Chau to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Acute Kidney Injury, Osteomyelitis and Bone Diseases, Infectious. VA Office of Research and Development sponsors the most, 2.

CMS Open Payments shows 394 general payments to Dr. Chau from 34 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Inari Medical, Inc. paid the most, $31,449.

Dmand AI lists 7 awards for Dr. Chau, most recently Helen Pierce Lata Scholarship in 2009.

Dr. Chau graduated from David Geffen School of Medicine at UCLA in 2011. Dr. Chau is a member of SVS.

Dr. Chau is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.